SK

Shobhna Khare

Active Director Director DIN 07790433
DIN 07790433 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Shobhna Khare

Data last updated:

Shobhna Khare is a Director at Experon Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Experon Pharmaceuticals Private Limited reported revenue of ₹1.9 Lakh (FY 2025).

DIN 07790433
Primary Designation Director
Industry Pharma
First Appointment 01 May 2017
Oldest Company Age 9 yrs
Largest company Experon Pharmaceuticals Private Limited · ₹1.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 May 20172017₹1.9 Lakh (FY 2025)Active

Board colleagues of Shobhna Khare

NameDINCompanyDesignation
Aadarsh Vijay07790429Experon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Experon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shobhna Khare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shobhna Khare

Shobhna Khare currently holds 1 directorship: Experon Pharmaceuticals Private Limited (Director, since 01 May 2017, revenue ₹1.9 Lakh (FY 2025)).

Shobhna Khare was first appointed on 01 May 2017 as Director at Experon Pharmaceuticals Private Limited.

The current boards of Shobhna Khare's companies include Aadarsh Vijay (Experon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available